Pak Fah Yeow International Ltd
HKEX:239

Watchlist Manager
Pak Fah Yeow International Ltd Logo
Pak Fah Yeow International Ltd
HKEX:239
Watchlist
Price: 2.38 HKD Market Closed
Market Cap: 741.7m HKD

Relative Value

The Relative Value of one Pak Fah Yeow International Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 2.38 HKD, Pak Fah Yeow International Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Pak Fah Yeow International Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
30
vs Industry
44
Median 3Y
2.9
Median 5Y
3
Industry
2.6
vs History
46
vs Industry
42
Median 3Y
9
Median 5Y
10.4
Industry
21.4
vs History
20
vs Industry
50
Median 3Y
8.6
Median 5Y
9
Industry
16.4
vs History
25
vs Industry
34
Median 3Y
8.8
Median 5Y
9.3
Industry
22.8
vs History
14
vs Industry
63
Median 3Y
1
Median 5Y
0.8
Industry
2.2
vs History
39
vs Industry
67
Median 3Y
1.5
Median 5Y
1.8
Industry
2.9
vs History
49
vs Industry
78
Median 3Y
1.9
Median 5Y
2.2
Industry
5.5
vs History
52
vs Industry
51
Median 3Y
3.4
Median 5Y
4
Industry
13
vs History
57
vs Industry
49
Median 3Y
3.6
Median 5Y
4.2
Industry
16.5
vs History
23
vs Industry
52
Median 3Y
5
Median 5Y
5.3
Industry
15.6
vs History
23
vs Industry
39
Median 3Y
5.1
Median 5Y
5.4
Industry
18.7
vs History
17
vs Industry
73
Median 3Y
0.7
Median 5Y
0.6
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Pak Fah Yeow International Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
Pak Fah Yeow International Ltd
HKEX:239
741.7m HKD 3.7 10.5 3.9 3.9
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.6 56.7 38 40.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.5B USD 5.4 19.8 16.2 21.1
CH
Roche Holding AG
SIX:ROG
268.8B CHF 4.4 28.5 12.1 14.2
UK
AstraZeneca PLC
LSE:AZN
219.6B GBP 5.1 31.5 108.7 159.1
US
Merck & Co Inc
NYSE:MRK
277.5B USD 4.3 14.6 10.3 12.2
CH
Novartis AG
SIX:NOVN
219.4B CHF 4.9 19.1 12.1 15.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.6 10.9 12.6
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.8B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
HK
Pak Fah Yeow International Ltd
HKEX:239
Average P/E: 23.4
10.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
56.7
54%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.5
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.5
37%
0.9
US
Merck & Co Inc
NYSE:MRK
14.6
15%
1
CH
Novartis AG
SIX:NOVN
19.1
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.6
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
HK
Pak Fah Yeow International Ltd
HKEX:239
Average EV/EBITDA: 400.4
3.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.1
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
CH
Novartis AG
SIX:NOVN
12.1
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
HK
Pak Fah Yeow International Ltd
HKEX:239
Average EV/EBIT: 1 712.8
3.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40.7
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.1
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
CH
Novartis AG
SIX:NOVN
15.6
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5